Literature DB >> 17426457

High-throughput screening of stabilizers for respiratory syncytial virus: identification of stabilizers and their effects on the conformational thermostability of viral particles.

Salvador F Ausar1, Marianela Espina, Julie Brock, Nagarajan Thyagarayapuran, Robert Repetto, Lakshmi Khandke, C Russell Middaugh.   

Abstract

Respiratory syncytial virus (RSV) is the leading cause of severe respiratory infection in children worldwide. Recombinant live attenuated viral preparations are one of the most promising strategies for vaccination but they typically possess poor thermostability. In this work, a library of compounds was screened and stabilizers were selected based on their ability to inhibit the aggregation of RSV perturbed at 56 degrees C. After screening and selection of excipients, the conformational stability of the RSV proteins was evaluated in the presence of potential stabilizers. The secondary and tertiary structures as well as aggregation/dissociation of RSV were monitored using circular dichroism and second derivative UV absorption spectroscopies and light scattering, respectively, as a function of temperature (10-90 degrees C). RSV membrane fluidity was also evaluated by generalized polarization of Laurdan fluorescence. Screening experiments showed that a variety of sugars, amino acids, polyols and polyanions inhibited the aggregation of viral particles. Conformational stability studies demonstrated that the addition of sugars and polyols stabilized RSV as indicated by a significant increase in the transition melting temperature (Tm) of both the secondary and tertiary structures as well as the gel to liquid crystalline membrane transition. These results should provide the basis for rational development of more physically stable formulations of live attenuated RSV vaccines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17426457     DOI: 10.4161/hv.3.3.4149

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  8 in total

1.  Studies of culture conditions and environmental stability of human metapneumovirus.

Authors:  Sharon J Tollefson; Reagan G Cox; John V Williams
Journal:  Virus Res       Date:  2010-04-07       Impact factor: 3.303

2.  Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.

Authors:  Peter L Collins; Rachel Fearns; Barney S Graham
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

Review 3.  Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability.

Authors:  Tanya Clapp; Paul Siebert; Dexiang Chen; LaToya Jones Braun
Journal:  J Pharm Sci       Date:  2010-08-25       Impact factor: 3.534

4.  Biophysical and stabilization studies of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.

Authors:  Sumin Cai; Feng He; Hardeep S Samra; Luis M de la Maza; Maria E Bottazzi; Sangeeta B Joshi; C Russell Middaugh
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

5.  Screening vaccine formulations for biological activity using fresh human whole blood.

Authors:  Roger H Brookes; Jalil Hakimi; Yukyung Ha; Sepideh Aboutorabian; Salvador F Ausar; Manvi Hasija; Steven G Smith; Stephen M Todryk; Hazel M Dockrell; Nausheen Rahman
Journal:  Hum Vaccin Immunother       Date:  2014-01-08       Impact factor: 3.452

6.  Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release.

Authors:  Stephany Y Tzeng; Rohiverth Guarecuco; Kevin J McHugh; Sviatlana Rose; Evan M Rosenberg; Yingying Zeng; Robert Langer; Ana Jaklenec
Journal:  J Control Release       Date:  2016-05-11       Impact factor: 9.776

7.  Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months.

Authors:  Maria Pelliccia; Patrizia Andreozzi; Jayson Paulose; Marco D'Alicarnasso; Valeria Cagno; Manuela Donalisio; Andrea Civra; Rebecca M Broeckel; Nicole Haese; Paulo Jacob Silva; Randy P Carney; Varpu Marjomäki; Daniel N Streblow; David Lembo; Francesco Stellacci; Vincenzo Vitelli; Silke Krol
Journal:  Nat Commun       Date:  2016-11-30       Impact factor: 14.919

Review 8.  Arginine as a synergistic virucidal agent.

Authors:  Satoshi Ohtake; Tsutomu Arakawa; A Hajime Koyama
Journal:  Molecules       Date:  2010-03-08       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.